ctDNA (Circulating tumor DNA) has emerged as a key tool for detecting molecular residual disease after curative surgery in early-stage colorectal cancer, often identifying recurrence months before radiologic relapse and informing…
ctDNA (Circulating tumor DNA) has emerged as a key tool for detecting molecular residual disease after curative surgery in early-stage colorectal cancer, often identifying recurrence months before radiologic relapse and informing…